Annual CFI
$208.00 K
+$24.17 M+100.87%
December 31, 2023
Summary
- As of February 12, 2025, ABEO annual cash flow from investing activities is $208.00 thousand, with the most recent change of +$24.17 million (+100.87%) on December 31, 2023.
- During the last 3 years, ABEO annual CFI has risen by +$83.92 million (+100.25%).
- ABEO annual CFI is now -99.69% below its all-time high of $66.06 million, reached on December 31, 2021.
Performance
ABEO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$6.17 M
+$37.97 M+86.03%
September 30, 2024
Summary
- As of February 12, 2025, ABEO quarterly cash flow from investing activities is -$6.17 million, with the most recent change of +$37.97 million (+86.03%) on September 30, 2024.
- Over the past year, ABEO quarterly CFI has dropped by -$17.70 million (-153.49%).
- ABEO quarterly CFI is now -123.04% below its all-time high of $26.76 million, reached on September 30, 2021.
Performance
ABEO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$46.59 M
+$12.58 M+21.26%
September 30, 2024
Summary
- As of February 12, 2025, ABEO TTM cash flow from investing activities is -$46.59 million, with the most recent change of +$12.58 million (+21.26%) on September 30, 2024.
- Over the past year, ABEO TTM CFI has dropped by -$46.80 million (-22497.60%).
- ABEO TTM CFI is now -170.52% below its all-time high of $66.06 million, reached on December 31, 2021.
Performance
ABEO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ABEO Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.9% | -153.5% | -10000.0% |
| 3 y3 years | +100.3% | -123.0% | -173.0% |
| 5 y5 years | +100.2% | -132.1% | -177.7% |
ABEO Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.7% | +100.9% | -153.5% | +86.0% | -170.5% | +21.3% |
| 5 y | 5-year | -99.7% | +100.3% | -123.0% | +91.9% | -170.5% | +48.5% |
| alltime | all time | -99.7% | +100.2% | -123.0% | +91.9% | -170.5% | +48.5% |
Abeona Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.17 M(-86.0%) | -$46.59 M(-21.3%) |
| Jun 2024 | - | -$44.13 M(+464.6%) | -$59.16 M(+502.5%) |
| Mar 2024 | - | -$7.82 M(-167.8%) | -$9.82 M(-4821.2%) |
| Dec 2023 | $208.00 K(-100.9%) | $11.53 M(-161.5%) | $208.00 K(-100.6%) |
| Sep 2023 | - | -$18.74 M(-459.7%) | -$36.61 M(+125.7%) |
| Jun 2023 | - | $5.21 M(+135.7%) | -$16.22 M(-29.0%) |
| Mar 2023 | - | $2.21 M(-108.7%) | -$22.83 M(-4.7%) |
| Dec 2022 | -$23.96 M(-136.3%) | -$25.29 M(-1633.7%) | -$23.96 M(-357.0%) |
| Sep 2022 | - | $1.65 M(-218.0%) | $9.32 M(-72.9%) |
| Jun 2022 | - | -$1.40 M(-230.0%) | $34.44 M(-40.4%) |
| Mar 2022 | - | $1.07 M(-86.6%) | $57.76 M(-12.6%) |
| Dec 2021 | $66.06 M(-178.9%) | $8.00 M(-70.1%) | $66.06 M(+3.5%) |
| Sep 2021 | - | $26.76 M(+22.1%) | $63.84 M(+53.2%) |
| Jun 2021 | - | $21.92 M(+133.8%) | $41.67 M(+2617.9%) |
| Mar 2021 | - | $9.38 M(+62.2%) | $1.53 M(-101.8%) |
| Dec 2020 | -$83.71 M(-239.6%) | $5.78 M(+26.1%) | -$83.71 M(-7.4%) |
| Sep 2020 | - | $4.58 M(-125.2%) | -$90.44 M(+19.3%) |
| Jun 2020 | - | -$18.21 M(-76.0%) | -$75.80 M(+96.0%) |
| Mar 2020 | - | -$75.87 M(+7920.2%) | -$38.67 M(-164.5%) |
| Dec 2019 | $59.98 M(-170.5%) | -$946.00 K(-104.9%) | $59.98 M(-4.9%) |
| Sep 2019 | - | $19.23 M(+1.6%) | $63.04 M(+88.8%) |
| Jun 2019 | - | $18.92 M(-16.9%) | $33.38 M(-156.8%) |
| Mar 2019 | - | $22.77 M(+974.8%) | -$58.81 M(-30.9%) |
| Dec 2018 | -$85.09 M(+9793.7%) | $2.12 M(-120.3%) | -$85.09 M(-3.2%) |
| Sep 2018 | - | -$10.43 M(-85.8%) | -$87.91 M(+13.4%) |
| Jun 2018 | - | -$73.27 M(+1992.3%) | -$77.55 M(+1708.6%) |
| Mar 2018 | - | -$3.50 M(+397.4%) | -$4.29 M(+398.6%) |
| Dec 2017 | -$860.00 K(+65.7%) | -$704.00 K(+877.8%) | -$860.00 K(+394.3%) |
| Sep 2017 | - | -$72.00 K(+620.0%) | -$174.00 K(-30.4%) |
| Jun 2017 | - | -$10.00 K(-86.5%) | -$250.00 K(-31.7%) |
| Mar 2017 | - | -$74.00 K(+311.1%) | -$366.00 K(-29.5%) |
| Dec 2016 | -$519.00 K(-115.3%) | -$18.00 K(-87.8%) | -$519.00 K(-32.4%) |
| Sep 2016 | - | -$148.00 K(+17.5%) | -$768.00 K(+18.7%) |
| Jun 2016 | - | -$126.00 K(-44.5%) | -$647.00 K(-120.4%) |
| Mar 2016 | - | -$227.00 K(-15.0%) | $3.17 M(-6.4%) |
| Dec 2015 | $3.39 M(<-9900.0%) | -$267.00 K(+888.9%) | $3.39 M(-7.3%) |
| Sep 2015 | - | -$27.00 K(-100.7%) | $3.66 M(-0.7%) |
| Jun 2015 | - | $3.69 M(<-9900.0%) | $3.68 M(<-9900.0%) |
| Mar 2015 | - | -$9000.00(<-9900.0%) | -$9000.00(+800.0%) |
| Sep 2014 | - | $0.00(0.0%) | -$1000.00(-50.0%) |
| Jun 2014 | - | $0.00(0.0%) | -$2000.00(0.0%) |
| Mar 2014 | - | $0.00(-100.0%) | -$2000.00(0.0%) |
| Dec 2013 | -$2000.00(-84.6%) | -$1000.00(0.0%) | -$2000.00(-300.0%) |
| Sep 2013 | - | -$1000.00(-150.0%) | $1000.00(-107.7%) |
| Dec 2012 | -$13.00 K(-67.5%) | $2000.00(>+9900.0%) | -$13.00 K(-13.3%) |
| Sep 2012 | - | $0.00(-100.0%) | -$15.00 K(-6.3%) |
| Jun 2012 | - | -$2000.00(-84.6%) | -$16.00 K(-48.4%) |
| Mar 2012 | - | -$13.00 K(<-9900.0%) | -$31.00 K(-22.5%) |
| Dec 2011 | -$40.00 K(+471.4%) | $0.00(-100.0%) | -$40.00 K(0.0%) |
| Sep 2011 | - | -$1000.00(-94.1%) | -$40.00 K(+5.3%) |
| Jun 2011 | - | -$17.00 K(-22.7%) | -$38.00 K(+31.0%) |
| Mar 2011 | - | -$22.00 K(<-9900.0%) | -$29.00 K(+314.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | -$7000.00(+600.0%) | $0.00(-100.0%) | -$7000.00(0.0%) |
| Sep 2010 | - | $1000.00(-112.5%) | -$7000.00(-12.5%) |
| Jun 2010 | - | -$8000.00(<-9900.0%) | -$8000.00(<-9900.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2009 | -$1000.00(-100.2%) | $0.00(0.0%) | -$1000.00(-100.0%) |
| Sep 2009 | - | $0.00(0.0%) | -$2.33 M(+427.8%) |
| Jun 2009 | - | $0.00(-100.0%) | -$442.00 K(+474.0%) |
| Mar 2009 | - | -$1000.00(-100.0%) | -$77.00 K(-117.7%) |
| Dec 2008 | $436.00 K(-8820.0%) | -$2.33 M(-223.3%) | $436.00 K(+395.5%) |
| Sep 2008 | - | $1.89 M(+418.1%) | $88.00 K(-115.3%) |
| Jun 2008 | - | $365.00 K(-28.7%) | -$575.00 K(-1227.5%) |
| Mar 2008 | - | $512.00 K(-119.1%) | $51.00 K(-1120.0%) |
| Dec 2007 | -$5000.00(-99.8%) | -$2.68 M(-318.2%) | -$5000.00(-102.0%) |
| Sep 2007 | - | $1.23 M(+23.9%) | $253.00 K(-125.0%) |
| Jun 2007 | - | $991.00 K(+117.3%) | -$1.01 M(-50.3%) |
| Mar 2007 | - | $456.00 K(-118.8%) | -$2.03 M(-19.4%) |
| Dec 2006 | -$2.52 M(-126.0%) | -$2.42 M(+6820.0%) | -$2.52 M(-127.3%) |
| Sep 2006 | - | -$35.00 K(+9.4%) | $9.25 M(-4.4%) |
| Jun 2006 | - | -$32.00 K(-5.9%) | $9.68 M(-0.0%) |
| Mar 2006 | - | -$34.00 K(-100.4%) | $9.68 M(-0.4%) |
| Dec 2005 | $9.72 M(+1895.3%) | $9.35 M(+2285.5%) | $9.72 M(-4683.5%) |
| Sep 2005 | - | $392.00 K(-1406.7%) | -$212.00 K(-38.2%) |
| Jun 2005 | - | -$30.00 K(-850.0%) | -$343.00 K(-7.3%) |
| Mar 2005 | - | $4000.00(-100.7%) | -$370.00 K(-176.0%) |
| Dec 2004 | $487.00 K(-91.8%) | -$578.00 K(-321.5%) | $487.00 K(-84.8%) |
| Sep 2004 | - | $261.00 K(-557.9%) | $3.20 M(+10.9%) |
| Jun 2004 | - | -$57.00 K(-106.6%) | $2.89 M(+6.7%) |
| Mar 2004 | - | $861.00 K(-59.7%) | $2.70 M(-54.4%) |
| Dec 2003 | $5.93 M(+120.5%) | $2.14 M(-3985.5%) | $5.93 M(+12.3%) |
| Sep 2003 | - | -$55.00 K(-77.0%) | $5.28 M(+17.9%) |
| Jun 2003 | - | -$239.00 K(-105.9%) | $4.47 M(-1081.4%) |
| Mar 2003 | - | $4.08 M(+174.6%) | -$456.00 K(-117.0%) |
| Dec 2002 | $2.69 M(-26.9%) | $1.49 M(-273.5%) | $2.69 M(+144.6%) |
| Sep 2002 | - | -$857.00 K(-83.4%) | $1.10 M(-83.2%) |
| Jun 2002 | - | -$5.17 M(-171.5%) | $6.55 M(-52.1%) |
| Mar 2002 | - | $7.23 M(-7186.3%) | $13.67 M(+271.9%) |
| Dec 2001 | $3.67 M(-121.0%) | -$102.00 K(-102.2%) | $3.67 M(-39.3%) |
| Sep 2001 | - | $4.59 M(+135.2%) | $6.05 M(-222.4%) |
| Jun 2001 | - | $1.95 M(-170.6%) | -$4.95 M(-41.7%) |
| Mar 2001 | - | -$2.77 M(-221.4%) | -$8.48 M(-51.4%) |
| Dec 2000 | -$17.47 M(>+9900.0%) | $2.28 M(-135.5%) | -$17.47 M(-11.6%) |
| Sep 2000 | - | -$6.41 M(+304.8%) | -$19.75 M(+47.0%) |
| Jun 2000 | - | -$1.58 M(-86.5%) | -$13.44 M(+13.4%) |
| Mar 2000 | - | -$11.75 M(>+9900.0%) | -$11.86 M(>+9900.0%) |
| Dec 1999 | -$107.00 K(+7.0%) | -$7000.00(-93.0%) | -$107.00 K(+7.0%) |
| Sep 1999 | - | -$100.00 K(<-9900.0%) | -$100.00 K(<-9900.0%) |
| Jun 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1999 | - | $0.00 | $0.00 |
| Dec 1998 | -$100.00 K(-45.7%) | - | - |
| Dec 1997 | -$184.00 K(+384.2%) | - | - |
| Dec 1996 | -$38.00 K(<-9900.0%) | - | - |
| Dec 1995 | $0.00 | - | - |
FAQ
- What is Abeona Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Abeona Therapeutics?
- What is Abeona Therapeutics annual CFI year-on-year change?
- What is Abeona Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Abeona Therapeutics?
- What is Abeona Therapeutics quarterly CFI year-on-year change?
- What is Abeona Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Abeona Therapeutics?
- What is Abeona Therapeutics TTM CFI year-on-year change?
What is Abeona Therapeutics annual cash flow from investing activities?
The current annual CFI of ABEO is $208.00 K
What is the all time high annual CFI for Abeona Therapeutics?
Abeona Therapeutics all-time high annual cash flow from investing activities is $66.06 M
What is Abeona Therapeutics annual CFI year-on-year change?
Over the past year, ABEO annual cash flow from investing activities has changed by +$24.17 M (+100.87%)
What is Abeona Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ABEO is -$6.17 M
What is the all time high quarterly CFI for Abeona Therapeutics?
Abeona Therapeutics all-time high quarterly cash flow from investing activities is $26.76 M
What is Abeona Therapeutics quarterly CFI year-on-year change?
Over the past year, ABEO quarterly cash flow from investing activities has changed by -$17.70 M (-153.49%)
What is Abeona Therapeutics TTM cash flow from investing activities?
The current TTM CFI of ABEO is -$46.59 M
What is the all time high TTM CFI for Abeona Therapeutics?
Abeona Therapeutics all-time high TTM cash flow from investing activities is $66.06 M
What is Abeona Therapeutics TTM CFI year-on-year change?
Over the past year, ABEO TTM cash flow from investing activities has changed by -$46.80 M (-22497.60%)